Xie Jingjing, Wu Nansheng, Li Dongming, Xiong Shiyi, Dong Jinjiao, Wang Ruiling, Zheng Guodong, Li Jingen
College of Food Science and Engineering, Jiangxi Agricultural University, Nanchang 330045, China.
Choerospondias Axillaris Research Institute, Jiangxi Agricultural University, Nanchang 330045, China.
Int J Biol Macromol. 2025 Mar;296:139759. doi: 10.1016/j.ijbiomac.2025.139759. Epub 2025 Jan 10.
Iron deficiency anemia (IDA) is a prevalent nutritional deficiency problem. This study aimed to investigate the characteristics of Choerospondias axillaris polysaccharide-Fe (III) complex and its effect on IDA mice. CAP-Fe (III) complex was synthesized by co-thermal synthesis method with an iron content of 27.31 ± 0.97 %. The chelation of Fe reduced the crystallinity, increased the thermal stability and changed the morphological features of CAP, which was evidenced by XRD, TG, and SEM analysis. The probable existence of the β-FeOOH structure was supported by the characteristic absorption peaks in the FT-IR, XRD, and Mössbauer spectra. The CAP-Fe (III) complex showed a therapeutic effect on IDA mice, confirmed by improved erythroid parameters, iron levels, and oxidative stress. The results of gene expression levels determined by RT-qPCR demonstrated that the CAP-Fe (III) complex could regulate iron metabolism homeostasis, alleviate liver inflammation, and enhance intestinal barrier function. Furthermore, the dysbiosis of intestinal microbiota induced by IDA was effectively restored by CAP-Fe (III) complex, through enriching beneficial bacteria (Firmicutes, Blautia, Oscillibacter, Colidextribacter) and depleting harmful bacteria (Actinobacteria, Proteobacteria, Parasutterella, Faecalibaculum, Escherichia-Shigella). These findings suggested that CAP-Fe (III) may serve as a novel iron supplement for treating IDA.
缺铁性贫血(IDA)是一种普遍存在的营养缺乏问题。本研究旨在探讨南酸枣多糖 - 铁(III)配合物的特性及其对缺铁性贫血小鼠的影响。采用共热合成法合成了CAP - Fe(III)配合物,铁含量为27.31 ± 0.97%。XRD、TG和SEM分析表明,铁的螯合降低了CAP的结晶度,提高了热稳定性并改变了其形态特征。FT - IR、XRD和穆斯堡尔光谱中的特征吸收峰支持了β - FeOOH结构的可能存在。CAP - Fe(III)配合物对缺铁性贫血小鼠具有治疗作用,改善的红细胞参数、铁水平和氧化应激证实了这一点。RT - qPCR测定的基因表达水平结果表明,CAP - Fe(III)配合物可调节铁代谢稳态,减轻肝脏炎症并增强肠道屏障功能。此外,CAP - Fe(III)配合物通过富集有益菌(厚壁菌门、布劳特氏菌属、颤杆菌属、共生杆菌属)和减少有害菌(放线菌门、变形菌门、副萨特氏菌属、粪杆菌属、埃希氏菌 - 志贺氏菌属)有效恢复了缺铁性贫血诱导的肠道微生物群失调。这些发现表明,CAP - Fe(III)可能作为一种新型铁补充剂用于治疗缺铁性贫血。